What's Next for Bioinformatics?

I slipped into bioinformatics through the back door.

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

I slipped into bioinformatics through the back door. In 1992, while completing my pathology residency at Brigham and Women's Hospital in Boston, I became frustrated with my inability to combine my love of biological research with my hobby of tinkering with computers and developing software. So when I was offered the opportunity to spend a summer working with the software group at the Whitehead Institute/MIT Center for Genome Research, I jumped at it.

I joined the field of bioinformatics just a year after the term first appeared in the published literature (though people had been doing computational sequence analysis for many years by then), and I have watched it grow from an esoteric research niche to a core discipline that biologists cannot conceivably do without.

The early bioinformatics databases emphasized primary data capture. GenBank, established in the late 1980s, began with staff at Los Alamos National Laboratory (and later the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Lincoln Stein

    This person does not yet have a bio.

Published In

Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development